Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Triapine |
Trade Name | |
Synonyms | 3-AP|3-Apct|OCX-191|OCX 191|OCX191 |
Drug Descriptions |
Triapine is an inhibitor of ribonucleotide reductase that blocks DNA synthesis, which potentially reduces cell viability and inhibits tumor growth (PMID: 10692563). |
DrugClasses | |
CAS Registry Number | 236392-56-6 |
NCIT ID | C2242 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cediranib + Olaparib + Triapine | Cediranib Olaparib Triapine | 0 | 0 |
Cediranib + Triapine | Cediranib Triapine | 0 | 0 |
Cisplatin + Triapine | Cisplatin Triapine | 0 | 2 |
lutetium Lu 177 dotatate + Triapine | Triapine lutetium Lu 177 dotatate | 0 | 2 |
Olaparib + Triapine | Olaparib Triapine | 0 | 0 |
Temozolomide + Triapine | Temozolomide Triapine | 0 | 1 |
Triapine | Triapine | 0 | 1 |